FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance

Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues

(2015) Natalie S Shenker et al.   BMC CANCER

Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay

(2015) Tor W. Jensen et al.   JNCI-Journal of the National Cancer Institute

FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer

(2015) Bingchen Han et al.   Cell Reports

Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay

(2015) Tor W. Jensen et al.   JNCI-Journal of the National Cancer Institute

Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells

(2014) Livia Caizzi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients

(2013) Yuan Xu et al.   HISTOPATHOLOGY

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

(2013) Ashley Cimino-Mathews et al.   HUMAN PATHOLOGY

KDM4B is a Master Regulator of the Estrogen Receptor Signalling Cascade

(2013) Luke Gaughan et al.   NUCLEIC ACIDS RESEARCH

Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

(2013) Hisham Mohammed et al.   Cell Reports

GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility

(2012) V. Theodorou et al.   GENOME RESEARCH

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

(2012) Limin Xia et al.   HEPATOLOGY

High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients

(2012) Long-Xiao Wei et al.   TUMOR BIOLOGY

PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer

(2011) Luca Magnani et al.   PLoS Genetics

FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

(2010) P. S. Ray et al.   CANCER RESEARCH

FOXA1 is an essential determinant of ER  expression and mammary ductal morphogenesis

(2010) G. M. Bernardo et al.   DEVELOPMENT

Cooperative interaction between retinoic acid receptor-  and estrogen receptor in breast cancer

(2010) C. S. Ross-Innes et al.   GENES & DEVELOPMENT

Integrated Quantitative Analysis of the Phosphoproteome and Transcriptome in Tamoxifen-resistant Breast Cancer

(2010) Masaaki Oyama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

(2010) Sunil Badve et al.   MODERN PATHOLOGY

Indole-3-Carbinol Triggers Aryl Hydrocarbon Receptor-dependent Estrogen Receptor (ER)α Protein Degradation in Breast Cancer Cells Disrupting an ERα-GATA3 Transcriptional Cross-Regulatory Loop

(2010) Crystal N. Marconett et al.   MOLECULAR BIOLOGY OF THE CELL

FOXA1 is a key determinant of estrogen receptor function and endocrine response

(2010) Antoni Hurtado et al.   NATURE GENETICS

Clinical Application of Gene Expression Profiling in Breast Cancer

(2010) Joseph A. Sparano et al.   Surgical Oncology Clinics of North America

Enhancers: The abundance and function of regulatory sequences beyond promoters

(2009) Michael Bulger et al.   DEVELOPMENTAL BIOLOGY

BRCA1 Regulates Acetylation and Ubiquitination of Estrogen Receptor-α

(2009) Yongxian Ma et al.   MOLECULAR ENDOCRINOLOGY

Long range chromatin interactions involved in gene regulation

(2008) Marek Bartkuhn et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH